Search research articles
Contact Us
Filters
Showing results (11-20 of 26) with videos related to
Page
of 3
Sort By:
The Journal of Antimicrobial Chemotherapy
|
July 29, 2025
Hypertension and blood pressure changes with dolutegravir or comparator antiretroviral therapy in randomized trials through 96 weeks
Parul Patel, Ana Milinkovic, Richard Grove, et al.
Arthritis Research & Therapy
|
October 9, 2012
Predictors of mortality in connective tissue disease-associated pulmonary arterial hypertension: a cohort study
Gene-Siew Ngian, Wendy Stevens, David Prior, et al.
Healthcare (Basel, Switzerland)
|
January 20, 2021
Religious Coping, Depression and Anxiety among Healthcare Workers during the COVID-19 Pandemic: A Malaysian Perspective
Soon Ken Chow, Benedict Francis, Yit Han Ng, et al.
Toxicology and Applied Pharmacology
|
April 15, 2014
Flavin-containing monooxygenase S-oxygenation of a series of thioureas and thiones
Marilyn C Henderson, Lisbeth K Siddens, Sharon K Krueger, et al.
BJUI Compass
|
April 27, 2022
The utility of magnetic resonance imaging in prostate cancer diagnosis in the Australian setting
Jia Ying Isaac Tay, Ken Chow, Dominic J Gavin, et al.
Plos One
|
July 24, 2008
The CXCL12gamma chemokine displays unprecedented structural and functional properties that make it a paradigm of chemoattractant proteins
Patricia Rueda, Karl Balabanian, Bernard Lagane, et al.
BJUI Compass
|
April 27, 2022
Ductal adenocarcinoma of the prostate: A systematic review and meta-analysis of incidence, presentation, prognosis, and management
Nithesh Ranasinha, Altan Omer, Yiannis Philippou, et al.
Genome Medicine
|
August 19, 2020
Detection of ctDNA in plasma of patients with clinically localised prostate cancer is associated with rapid disease progression
Edmund Lau, Patrick McCoy, Fairleigh Reeves, et al.
Prostate Cancer and Prostatic Diseases
|
June 10, 2021
MSH2-deficient prostate tumours have a distinct immune response and clinical outcome compared to MSH2-deficient colorectal or endometrial cancer
Patrick McCoy, Stefano Mangiola, Geoff Macintyre, et al.
JCO Precision Oncology
|
July 29, 2021
Loss of <i>SNAI2</i> in Prostate Cancer Correlates With Clinical Response to Androgen Deprivation Therapy
Marek Cmero, Natalie J Kurganovs, Ryan Stuchbery, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 26) with videos related to
Sort By:
Page
of 3
The Journal of Antimicrobial Chemotherapy
|
July 29, 2025
Hypertension and blood pressure changes with dolutegravir or comparator antiretroviral therapy in randomized trials through 96 weeks
Parul Patel, Ana Milinkovic, Richard Grove, et al.
Arthritis Research & Therapy
|
October 9, 2012
Predictors of mortality in connective tissue disease-associated pulmonary arterial hypertension: a cohort study
Gene-Siew Ngian, Wendy Stevens, David Prior, et al.
Healthcare (Basel, Switzerland)
|
January 20, 2021
Religious Coping, Depression and Anxiety among Healthcare Workers during the COVID-19 Pandemic: A Malaysian Perspective
Soon Ken Chow, Benedict Francis, Yit Han Ng, et al.
Toxicology and Applied Pharmacology
|
April 15, 2014
Flavin-containing monooxygenase S-oxygenation of a series of thioureas and thiones
Marilyn C Henderson, Lisbeth K Siddens, Sharon K Krueger, et al.
BJUI Compass
|
April 27, 2022
The utility of magnetic resonance imaging in prostate cancer diagnosis in the Australian setting
Jia Ying Isaac Tay, Ken Chow, Dominic J Gavin, et al.
Plos One
|
July 24, 2008
The CXCL12gamma chemokine displays unprecedented structural and functional properties that make it a paradigm of chemoattractant proteins
Patricia Rueda, Karl Balabanian, Bernard Lagane, et al.
BJUI Compass
|
April 27, 2022
Ductal adenocarcinoma of the prostate: A systematic review and meta-analysis of incidence, presentation, prognosis, and management
Nithesh Ranasinha, Altan Omer, Yiannis Philippou, et al.
Genome Medicine
|
August 19, 2020
Detection of ctDNA in plasma of patients with clinically localised prostate cancer is associated with rapid disease progression
Edmund Lau, Patrick McCoy, Fairleigh Reeves, et al.
Prostate Cancer and Prostatic Diseases
|
June 10, 2021
MSH2-deficient prostate tumours have a distinct immune response and clinical outcome compared to MSH2-deficient colorectal or endometrial cancer
Patrick McCoy, Stefano Mangiola, Geoff Macintyre, et al.
JCO Precision Oncology
|
July 29, 2021
Loss of <i>SNAI2</i> in Prostate Cancer Correlates With Clinical Response to Androgen Deprivation Therapy
Marek Cmero, Natalie J Kurganovs, Ryan Stuchbery, et al.
Page
of 3